COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Pappas Ventures names Michael Grey Venture Partner
News | 01. 11. 2010
Pappas Ventures today announced that industry veteran Michael Grey has been named a venture partner.
